Table 5.

Genetic susceptibility score (GSS) to the concurrent regimen for patients with viral loads $\ge$ 1000 copies/mL (N = 33).

The regimen for all patients was TDF + 3TC + DTG, except for CR-063 and MC-400 it was ABC + 3TC + LPV/r, CR-119 had ABC + 3TC + ATV/r, MC-111 and MC-222 had ABC + 3TC + DTG.

TDF tenofovir, ABC abacavir, 3TC lamivudine, DTG dolutegravir, ATV/r atazanavir boosted by ritonavir, LPV/r lopinavir boosted by ritonavir, GSS genetic susceptibility score, GF genotypic failure, NA not applicable because of some missing value(s).